GENE ONLINE|News &
Opinion
Blog

Stock Market
Special BIO2022
BIO 2022: Options for Raising Capital in a Down Market
2022-08-01
IPO Asia
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
IPO
Is the Path to Public Market Smooth? A Candid Discussion on SPACs
2021-06-15
Trials & Approvals
Citius Pharma Makes Calculated Market Moves with Phase 3 Results Looming for Potential Blockbuster Product
2021-02-21
IPO
Vor BioPharma Surpasses $1 Billion Valuation After IPO
2021-02-07
Ranking & Reports
2020-China’s Biomedicine Industry Ushers New Upsurge of IPO listings
2020-12-07
IPO Codiak Biosciences
Cambridge Startup’s Take Two at Public Debut is Off to a Slow Start
2020-10-18
Trials & Approvals
True to Analyst Predictions, Amarin’s Shares Crash Following Vascepa Patent Invalidation
2020-03-31
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top